Neoliquiritin

CAS No. 5088-75-5

Neoliquiritin( —— )

Catalog No. M19441 CAS No. 5088-75-5

Neoliquiritin may possess ytotoxiciy and Tumor-specificity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 95 In Stock
5MG 86 In Stock
10MG 122 In Stock
25MG 204 In Stock
50MG 296 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Neoliquiritin
  • Note
    Research use only, not for human use.
  • Brief Description
    Neoliquiritin may possess ytotoxiciy and Tumor-specificity.
  • Description
    Neoliquiritin may possess ytotoxiciy and Tumor-specificity.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    5088-75-5
  • Formula Weight
    418.4
  • Molecular Formula
    C21H22O9
  • Purity
    >98% (HPLC)
  • Solubility
    Pyridine Methanol etc.:Soluble;Ethanol:Soluble;DMSO:Soluble
  • SMILES
    C1[C@H](OC2=C(C1=O)C=CC(=C2)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)C4=CC=C(C=C4)O
  • Chemical Name
    (S)-2-(4-hydroxyphenyl)-7-(((2S3R4S5S6R)-345-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)chroman-4-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • 4-Demethyl Picropodo...

    4'-Demethyl Picropodophyllotoxin

  • thermospermine

    Thermospermine is a structural isomer of spermine and plays a role in the repression of xylem differentiation. Thermospermine can be used in studies about acting as a plant growth regulator and serving in the control of wood biomass production.

  • TAK-448

    TAK-448 (MVT-602) is a potent and full KISS1R agonist with an IC50 of 460 pM and an EC50 of 632 pM.TAK-448 has been used in trials studying the treatment of Prostate Cancer, Low Testosterone, Prostatic Neoplasms, and Hypogonadotropic Hypogonadism.